Children under five account for 30 per cent of deaths due to food borne diseases globally: WHO

Calls food borne diseases a ‘global concern’

Vaccine troubles

WHO accedes to paediatricians' concern over Hepatitis B

Cancerous virus

Researchers believe that hepatitis virus can cause cancer

Shelling out remedies

Marine organisms like bivalves hold cures for viral diseases

Defective blood-test kits in West Bengal

MONEYMAKERS

Hepatitis C: India has failed to tackle the deadly disease

Chronic HCV infection accounts for 12-32 per cent of liver cancer and 10-20 per cent of cirrhosis cases in India. Most people with chronic …

Officials push five-in-one vaccine

Pentavalent vaccine linked to child deaths in Sri Lanka, Bhutan; ball in high court

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Muted response

Hepatitis C is a growing problem in India, but government has no programme to manage the disease

Mumbai hit with diseases after rains

‘Adenovirus is not new. Yet, we’ve never linked it with severe hepatitis’

Matthew R Vogt on link between acute flaccid myelitis & current acute paediatric hepatitis outbreak

What to do about Liberia's island colony of abandoned lab chimps?

These chimpanzees were intentionally infected with hepatitis and other pathogens to help develop a range of vaccines

Bytes

Bytes

Gilead expands hepatitis C licensing pacts with Indian companies

New programme introduces coercion and policing upon medical providers and may result in treatment interruptions for patients

How pure are their claims?

Market for water purifiers booms, but consumers cannot be sure of quality in absence of regulations

COVID-19 : Why vaccinating children may be crucial

Vaccinating children will protect them against post-infectious conditions such as multisystem inflammatory syndrome; reduce risk of infection in …

UNICEF to procure controversial pentavalent vaccine at lowest-ever prices

This step will significantly increase the distribution of pentavalent vaccine, which has been blamed for adverse health effects

After India, China rejects patent claim for hepatitis C drug Sovaldi

Activists claim that the drug was developed using previously published information and an existing compound

New hepatitis drug to cost more in middle income nations; activists cry foul

Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …

The 'vaccinegate' of Italy

A study in Italy has found major contaminants in vaccines that are used the world over

Policy draft backs new, expensive vaccines

Health experts say they are not essential enough to be part of national immunisation programme

Effective oral drug for Hepatitis C approved by European agencies

Various patent barriers hinder its availability and affordability, especially in countries with high burden of disease

Hepatitis C medication remains beyond reach

Price control may ensure patients complete their course of medication